GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Polynovo Ltd (ASX:PNV) » Definitions » 3-Year Revenue Growth Rate

Polynovo (ASX:PNV) 3-Year Revenue Growth Rate : 49.50% (As of Dec. 2024)


View and export this data going back to 1998. Start your Free Trial

What is Polynovo 3-Year Revenue Growth Rate?

Polynovo's Revenue per Share for the six months ended in Dec. 2024 was A$0.09.

During the past 12 months, Polynovo's average Revenue per Share Growth Rate was 38.30% per year. During the past 3 years, the average Revenue per Share Growth Rate was 49.50% per year. During the past 5 years, the average Revenue per Share Growth Rate was 46.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of Polynovo was 78.30% per year. The lowest was 40.80% per year. And the median was 48.05% per year.


Competitive Comparison of Polynovo's 3-Year Revenue Growth Rate

For the Medical Devices subindustry, Polynovo's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Polynovo's 3-Year Revenue Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Polynovo's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Polynovo's 3-Year Revenue Growth Rate falls into.


;
;

Polynovo 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.


Polynovo  (ASX:PNV) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.


Polynovo 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Polynovo's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Polynovo Business Description

Traded in Other Exchanges
Address
320 Lorimer Street, Unit 2, Port Melbourne, VIC, AUS, 3207
Polynovo earns most of its revenue from US sales of its NovoSorb Biodegradable Temporizing Matrix, or NovoSorb BTM. The product is a patented biodegradable synthetic scaffold to support the regeneration of the dermis when lost through surgery, trauma, burns, or other causes of tissue loss. Once the product is applied to a wound, it takes a few weeks for the dermal layer to fully integrate within the polymer scaffold before a clinician can delaminate the outer layer. A small wound would then close either naturally or with a dressing, while a larger wound would close through a split-skin graft or alternative product such as Avita's RECELL. NovoSorb BTM then slowly degrades to harmless byproducts which are fully absorbed in roughly 18 months.

Polynovo Headlines

No Headlines